Antibiotic resistance patterns of Escherichia coli urinary isolates and comparison with antibiotic consumption data over 10  years, 2005–2014

ConclusionEscherichia coli isolates from community MSU samples have high rates of non-susceptibility to trimethoprim and co-amoxiclav. Nitrofurantoin remains the best empiric therapy for cystitis. Increasing non-susceptibility to co-amoxiclav and piperacillin –tazobactam in hospital isolates is concerning. Ciprofloxacin non-susceptibility is increasing faster in the community than in hospital. A sharp reduction in hospital fluoroquinolone consumption did not result in a significant reduction in ciprofloxacin non-susceptibility of hospitalE. coli isolates.
Source: Irish Journal of Medical Science - Category: Journals (General) Source Type: research